Navigation Links
Red wine may lower lung cancer risk
Date:10/6/2008

PHILADELPHIA Moderate consumption of red wine may decrease the risk of lung cancer in men, according to a report in the October issue of Cancer Epidemiology, Biomarkers & Prevention a journal of the American Association for Cancer Research.

"An antioxidant component in red wine may be protective of lung cancer, particularly among smokers," said Chun Chao, Ph.D., a research scientist at Kaiser Permanente Department of Research and Evaluation in Pasadena, California.

Chao analyzed data collected through the California Men's Health Study, which linked clinical data from California's health system with self-reported data from 84,170 men aged 45 to 69 years. Researchers obtained demographics and lifestyle data from surveys computed between 2000 and 2003, and identified 210 cases of lung cancer.

Researchers measured the effect of beer, red wine, white wine and liquor consumption on the risk of lung cancer. Adjustments were made for age, race/ethnicity, education, income, body mass index, history of chronic obstructive pulmonary disease or emphysema, and smoking history.

Among the study participants, there was on average a two percent lower lung cancer risk associated with each glass of red wine consumed per month. The most substantial risk reduction was among smokers who drank one to two glasses of red wine per day. The researchers reported a 60 percent reduced lung cancer risk in these men. Researchers warned men to stop smoking as the best way to reduce lung cancer risk; noting that even men who drank one to two glasses of red wine per day still face higher lung cancer risk than do non-smokers.

No clear associations with lung cancer were noted for consumption of white wine, beer, or liquor. "Red wine is known to contain high levels of antioxidants. There is a compound called resveratrol that is very rich in red wine because it is derived from the grape skin. This compound has shown significant health be
'/>"/>

Contact: Jeremy Moore
Jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related biology news :

1. Cholesterol-lowering drugs and the effect on muscle repair and regeneration
2. Robotic surgery lowers risk of a rare but serious complication of gastric bypass
3. Flooding might help lower gas emission from wetlands
4. Combining advanced medical and information technologies offers pathway to lower health care costs
5. UT Knoxville professor finds unexpected key to flowering plants diversity
6. Want a reason to love your lower belly fat? Its rich in stem cells
7. Californias wildflowers are disappearing, new book by UCR ecologist cautions
8. Silicons effect on sunflowers studied
9. A new idea for how anti-aging products delay ripening of fruit and wilting of flowers
10. Sunflower debate ends in Mexico, researchers say
11. Ancient sunflower fuels debate about agriculture in the Americas

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...c snowmelt that occurred during the 2008-09 austra...ive phases for two main climate drivers, ENSO (El ...sphere Annular Mode), according to Dr. Marco Tedes...ences at The City College of New York. , Profe...at the CUNY Graduate Center, added that Antarctic ...
(Date:12/2/2009)...strengthen the evidence that people who smoke ciga...d risk for developing colorectal cancer, even afte...vides one more reason not to smoke, or to quit as ...hun, M.D., M.S., vice president emeritus, epidemio...cer Society. "Colorectal cancer should be added to...
(Date:12/2/2009)...dolescents exposed to cigarette smoking scenes in ...lves, and this may be part of the acculturation pr...g to new study findings. , "Our study supports a...ghlights the global implementation of the World He...Control, which includes guidelines for countries t...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Cigarette smoking increases colorectal cancer risk 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2MedApps Receives FDA Clearance on a New Way to Bring Cost Effective Remote Health Monitoring to More People 48261 1MedApps Receives FDA Clearance on a New Way to Bring Cost Effective Remote Health Monitoring to More People 48261 2Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 1Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 2Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 3Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 4Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 5Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 6DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec 28R 29 in GI GVHD 4572 1DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec 28R 29 in GI GVHD 4572 2DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec 28R 29 in GI GVHD 4572 3DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec 28R 29 in GI GVHD 4572 4DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec 28R 29 in GI GVHD 4572 5DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec 28R 29 in GI GVHD 4572 6DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec 28R 29 in GI GVHD 4572 7
...ccompanied by nonspecific immune suppression thera...unosuppressants can cause infection, hypertension,...fore, specific suppression of the T cells that att...wn that anergic T cells (immune T cells that do no...artificial environment outside the living organism...
...tabolic Pharmaceuticals Limited recently announced...oxin. The company will begin clinical trials in hu...toxin in normal males, and later its effectiveness...diabetes. , From the University of Melbourne,s Dep...the recently launched Bio21 Institute, Associate P...
...g culprits in delivering pollutants ?through their... a new Canadian study shows. , The most common for...ble for transporting most of the human-made contam... found. "The effect is to elevate concentrations o... 60 times that of areas not influenced by seabird ...
Other Biology News:Molecular miners find pain relief drugs from the sea 2Molecular miners find pain relief drugs from the sea 3Industrial contaminants spread by seabirds in High Arctic, new Canadian study shows 2
(Date:12/3/2009)... , DALLAS, Dec. 3 A...d: ACCP), today provided an update on its European...tment for oral mucositis, a debilitating side effe... is commercially launched by Access, partner, SpeP... Germany, Italy, Norway, Greece and Sweden. Access...
(Date:12/3/2009)... PHILADELPHIA, Dec. 3 Sh...ecialty biopharmaceutical company, today announced...ket withdrawal of one lot of the Attention-Deficit...4; . Shire is taking this action because some Dayt...meet their release liner removal specification, an...
(Date:12/3/2009)... WALTHAM, Mass., Dec. 3 ..., a global leader in enabling individuals to take ...of rapid diagnostics and health management, has de... B Convertible Perpetual Preferred Stock ( IMA-PB)...stock in an amount per share equal to the quotient...
(Date:12/3/2009)... , NEW DELHI, India, Dec. 3 /PRNewswire-A...e Officer at Shenzhen Beike Biotechnology Co. Ltd....erence on High-Risk Diabetic,Foot Care in New Delh...ing,stem cell research and regenerative medicine c...e Indian Podiatry Association (IPA), aimed,to help...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...y, Inc. has reached the public sector with the sa... Stratton VA Medical Center in Albany, N.Y., a ho...irs , now is treating patients with TomoTherapy,s ...,The TomoTherapy Hi-Art System combines CT imaging...herapy that targets tumors while limiting damage t...
... elevator next to a venture capitalist who could i...he first thing about it yet. , ,You have 90 secon... of the Elevator Pitch Olympics, a yearly event at... a panel of eight investors dished out advice and ...sented their businesses in front of an audience. ,...
...ollow Wisconsin,s race for governor only by watchi...re primarily about gun control, the death penalty,... and the proposed constitutional ban on gay marria...ry citizens about problems that matter most to the... priorities in this election are much more basic a...
Other Biology Technology:9 tips for making 90 seconds count in an investment pitch 2What citizens don't ask political candidates 2What citizens don't ask political candidates 3
Rabbit Anti-EEF2K Monoclonal Antibody, Unconjugated, Clone EP881Y from Abcam
Human Regulatory T cell (Foxp3 / CD4 / CD25) Flow Cytometry staining Kit from eBioscience
Weinreb Linker from ChemPep, Inc.
Goat Anti-VAV2 Antibody, Unconjugated from Raybiotech, Inc.
Biology Products: